secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2026-06-04T20:37:03+00:00
Accession:  0001193125-26-257558
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fate updates corporate presentation for EULAR 2026; no specific new data in exhibit
--------------------------------------------------------------------------------

- Company filed an updated corporate presentation for use at the EULAR 2026 Congress on June 4, 2026.
- Presentation focuses on cell therapies for autoimmune diseases and cancer; ticker FATE listed on Nasdaq.
- No financial results, pipeline updates, or concrete milestones disclosed in the excerpted exhibit.
- Event is a routine update of investor materials; materiality is limited given lack of specific numbers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000119312526257558/0001193125-26-257558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000119312526257558/d83385d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer